Trethera Announces FDA Orphan Drug Designation Granted to TRE-515 in the Treatment of…
LOS ANGELES, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the…